Skip to main content
Clinical Trials/ISRCTN24929928
ISRCTN24929928
Completed
Not Applicable

A neuroscience perspective on anxiety proneness - sex differences, monoaminergic pathways and treatment response: a randomised controlled trial

ppsala University (Sweden)0 sites96 target enrollmentAugust 2, 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Social anxiety disorder (social phobia)
Sponsor
ppsala University (Sweden)
Enrollment
96
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 2, 2011
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ppsala University (Sweden)

Eligibility Criteria

Inclusion Criteria

  • 1\. Social anxiety disorder (social phobia), according to DSM\-IV, must be the main diagnosis as assessed with the structured clinical interview for DSM disorders (SCID)
  • 2\. Otherwise somatically healthy
  • 3\. Age 18 or older but not postmenopausal
  • 4\. Willingness to participate in a symptom provocation brain imaging trial
  • Healthy controls:
  • 1\. No psychiatric diagnosis and otherwise somatically healthy
  • 2\. Age 18 or older but not postmenopausal
  • 3\. Willingness to participate in a brain imaging trial

Exclusion Criteria

  • 1\. Treatment of social anxiety within the three months preceding the study
  • 2\. Current serious or dominant psychiatric disorder other than social anxiety disorder (e.g. psychosis, major depressive disorder, bipolar disorder)
  • 3\. Suicidal ideation
  • 4\. Chronic use of prescribed medication that could influence the results
  • 5\. Abuse of alcohol or narcotics
  • 6\. Pregnancy or planned pregnancy during the study period
  • 7\. Menopause
  • 8\. Previous positron emission tomography (PET) examination
  • 9\. Contraindications for MRI investigations (e.g. implants or other metal objects in the body, brain and heart operations)

Outcomes

Primary Outcomes

Not specified

Similar Trials